DiagnoCure sales and marketing update

Dako Corp. (Carpenteria, Calif.) launched in the U.S. CUR's ImmunoCyt, a non-invasive cytopathologic adjunctive diagnostic for recurring bladder cancer that uses monoclonal antibodies to detect a mu...